Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jolien Van den Bossche
MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-Small Cell Lung Cancer Adenocarcinoma Patients
Journal of Cancer
Oncology
Related publications
CD24+/CD38- As New Prognostic Marker for Non-Small Cell Lung Cancer
Multidisciplinary Respiratory Medicine
Pulmonary
Respiratory Medicine
Prognostic Gene Signatures for Non-Small-Cell Lung Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer
Journal of Clinical & Cellular Immunology
P2.16-43 Diabetes Is a Negative Prognostic Factor in Non-Small Cell Lung Cancer Patients Undergoing Resectional Surgery
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.03-31 Periostin Is a Negative Prognostic Factor and Promotes Cancer Cell Proliferation in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients
Oncotarget
Oncology
Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer
Advances in Lung Cancer
Prognostic Impact of Serum Transthyretin in Patients With Non‑small Cell Lung Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Prognostic Value of Number of Negative Lymph Node in Patients With Stage II and IIIa Non-Small Cell Lung Cancer
Oncotarget
Oncology